These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 19906350

  • 1. Do glutamatergic agents represent a new class of antidepressant drugs? Part 1.
    Sanacora G.
    J Clin Psychiatry; 2009 Oct; 70(10):1473-5. PubMed ID: 19906350
    [No Abstract] [Full Text] [Related]

  • 2. Do glutamatergic agents represent a new class of antidepressant drugs? Part 2.
    Sanacora G.
    J Clin Psychiatry; 2009 Nov; 70(11):1604-5. PubMed ID: 20031105
    [No Abstract] [Full Text] [Related]

  • 3. An update on the role of glutamate in the pathophysiology of depression.
    Mitchell ND, Baker GB.
    Acta Psychiatr Scand; 2010 Sep; 122(3):192-210. PubMed ID: 20105149
    [Abstract] [Full Text] [Related]

  • 4. Glutamate and depression: clinical and preclinical studies.
    Paul IA, Skolnick P.
    Ann N Y Acad Sci; 2003 Nov; 1003():250-72. PubMed ID: 14684451
    [Abstract] [Full Text] [Related]

  • 5. On the role of metabotropic glutamate receptors in the mechanisms of action of antidepressants.
    Pałucha A, Pilc A.
    Pol J Pharmacol; 2002 Nov; 54(6):581-6. PubMed ID: 12866712
    [Abstract] [Full Text] [Related]

  • 6. The role of glutamate on the action of antidepressants.
    Hashimoto K.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug 15; 35(7):1558-68. PubMed ID: 20600468
    [Abstract] [Full Text] [Related]

  • 7. Two case studies of patients with major depressive disorder given low-dose (subanesthetic) ketamine infusions.
    Correll GE, Futter GE.
    Pain Med; 2006 Aug 15; 7(1):92-5. PubMed ID: 16533209
    [No Abstract] [Full Text] [Related]

  • 8. [Modern aspects of investigation and clinical application of glutamatergic agents].
    Petrov VI, Onishchenko NV.
    Eksp Klin Farmakol; 2002 Aug 15; 65(4):66-70. PubMed ID: 12449079
    [Abstract] [Full Text] [Related]

  • 9. Amyloid beta peptides and glutamatergic synaptic dysregulation.
    Parameshwaran K, Dhanasekaran M, Suppiramaniam V.
    Exp Neurol; 2008 Mar 15; 210(1):7-13. PubMed ID: 18053990
    [Abstract] [Full Text] [Related]

  • 10. Emerging role of glutamate in the pathophysiology of major depressive disorder.
    Hashimoto K.
    Brain Res Rev; 2009 Oct 15; 61(2):105-23. PubMed ID: 19481572
    [Abstract] [Full Text] [Related]

  • 11. [The role of cluster receptor state in synaptic plasticity].
    Murzina GB.
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2008 Oct 15; 58(3):276-93. PubMed ID: 18689239
    [Abstract] [Full Text] [Related]

  • 12. Glutamate-based antidepressants: 20 years on.
    Skolnick P, Popik P, Trullas R.
    Trends Pharmacol Sci; 2009 Nov 15; 30(11):563-9. PubMed ID: 19837463
    [Abstract] [Full Text] [Related]

  • 13. The involvement of glutamate in the pathophysiology of depression.
    Palucha A, Pilc A.
    Drug News Perspect; 2005 May 15; 18(4):262-8. PubMed ID: 16034483
    [Abstract] [Full Text] [Related]

  • 14. Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders?
    Nicoletti F, Bruno V, Copani A, Casabona G, Knöpfel T.
    Trends Neurosci; 1996 Jul 15; 19(7):267-71. PubMed ID: 8799968
    [Abstract] [Full Text] [Related]

  • 15. Ketamine and other potential glutamate antidepressants.
    Dutta A, McKie S, Deakin JFW.
    Psychiatry Res; 2015 Jan 30; 225(1-2):1-13. PubMed ID: 25467702
    [Abstract] [Full Text] [Related]

  • 16. [Glutamatergic neurotransmission, depression and antidepressants].
    Ferrero A, Cereseto M.
    Vertex; 2004 Jan 30; 15(56):91-8. PubMed ID: 15243652
    [Abstract] [Full Text] [Related]

  • 17. Neuroprotection by cell permeable TAT-mGluR1 peptide in ischemia: synergy between carrier and cargo sequences.
    Wei Xu, Miou Zhou, Baudry M.
    Neuroscientist; 2008 Oct 30; 14(5):409-14. PubMed ID: 18000067
    [Abstract] [Full Text] [Related]

  • 18. Repeated 4-aminopyridine induced seizures diminish the efficacy of glutamatergic transmission in the neocortex.
    Világi I, Dobó E, Borbély S, Czégé D, Molnár E, Mihály A.
    Exp Neurol; 2009 Sep 30; 219(1):136-45. PubMed ID: 19445932
    [Abstract] [Full Text] [Related]

  • 19. Glutamatergic Modulators in Depression.
    Henter ID, de Sousa RT, Zarate CA.
    Harv Rev Psychiatry; 2018 Sep 30; 26(6):307-319. PubMed ID: 29465478
    [Abstract] [Full Text] [Related]

  • 20. The "blue" side of glutamatergic neurotransmission: NMDA receptor antagonists as possible novel therapeutics for major depression.
    Szakacs R, Janka Z, Kalman J.
    Neuropsychopharmacol Hung; 2012 Mar 30; 14(1):29-40. PubMed ID: 22427468
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.